Via tax-free allotment to company shareholders, Rennova Health Inc. intends to transition its Advanced Molecular Services Group to a publicly traded entity by late September pending appropriate paperwork with the SEC and other conditions. Read More »
Takeda Pharmaceuticals Ltd. and Seattle Genetics Inc. recently announced that their Adcetris drug, which was created to treat advanced Hodgkin lymphoma, met its primary endpoint during the Phase 3 Echelon-1 clinical trial. Read More »
DelMar Pharmaceuticals of Vancouver, British Columbia recently appointed two individuals to its board of directors, in alignment with its mission both to strengthen the board and to allow for expansion of its current executive’s scope. Read More »
Two third generation hepatitis B vaccine trials to enroll 4,800 participants in the U.S., Canada and Europe. Read More »
Certain workplace necessities just became easier for employees seeking routine screenings and basic health care services thanks to a partnership between CVS MinuteClinic and Alere eScreen Occupational Health Network (EOHN) expanding access via participating locations. Read More »
Helps reduce Parkinson's symptoms when primary medications are not completely effective; patients' voluntary movements not impaired by addition of XADAGO. Read More »
Final study shows immediate reversal of Pradaxa; anticoagulant drug's effect negated by Praxbind. Read More »
GeoVax announced promising results in testing a Lassa hemorrhagic fever vaccine (LASV) in mice. Read More »
Aridis Pharmaceuticals Inc. recently announced positive results for its Phase 2a trial of Salvecin for treating severe pneumonia caused by Staphylococcus aureus. Read More »
ESSA Pharma Inc. recently announced early data from its Phase 1 clinical trial for EPI-506, an anti-tumor drug. Read More »
Zavante Therapeutics Inc. recently announced that multiple in vitro studies provide support for Zolyd, combined with certain other antibiotics, as a bacteria killer. Read More »
Novo Nordisk recently announced positive results from its phase 3b Dual VII clinical trial for Xultophy, a product created to treat type 2 diabetes. Read More »
Sunovion Pharmaceuticals Inc.'s supplemental New Drug Application for a medication addressing bipolar conditions has won acceptance for review by the U.S. Food and Drug Administration. Read More »
With the brand-new option to make “best-of-breed” choices at the pharmacy counter, existing Premier Inc. members may now take advantage of pricing solutions through a new partnership between Premier and supplier Swisslog Healthcare. Read More »
Theravance Biopharma Inc. recently presented positive data from multiple Vibativ studies at the ASM Microbe 2017 Meeting, the annual gathering of the American Society for Microbiology held in New Orleans. Read More »
Genentech recently released positive results for its Phase III ALEX study analyzing Alecensa, a drug that treats anaplastic lymphoma kinase-positive advanced non-small cell lung cancer. Read More »
Sanofi and Regeneron Pharmaceuticals recently announced positive results from two Praluent-focused Phase 3b/4 Odyssey-DM trials involving diabetes patients. Read More »
Genentech, a member of the Roche Group, along with the Breast International Group, Breast European Adjuvant Study Team and Frontier Science Foundation, recently announced positive results from the Phase III Aphinity study for Perjeta and Herceptin-based adjuvant treatment in combating breast cancer. Read More »
Generic drug makers insist they attempted to work with state legislators in Maryland to carve out a bill to curb "price gouging," but they ignored the advice and passed an unconstitutional law, according to an industry group. Read More »
Pharmaceutical Care Management Association (PCMA) recently announced that it has initiated litigation proceedings in federal court in response to a pair of state laws which it believes jeopardizes patient safety and concurrently increases prescription costs. Read More »
Alerts Sign-up
